USPTO serial 79320875
CYBO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 24, 2023
- Examiner
- LIU, PHILIP HUAI-EN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CYBO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Holly M. Ford Lewis
Holly M. Ford Lewis Oliff PLCP.O. Box 320850Alexandria, VA 22320-4850UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Cytometers for medical diagnostic use; flow cytometers for medical diagnostic uses; flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; medical image processors; nuclear medicine diagnostic imaging apparatus; medical imaging devices for cells; medical imaging apparatus; medical imaging apparatus with embedded operating system software; medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; devices for measuring blood sugar for medical purposes; medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical diagnostic apparatus for testing cancer cells; cytology brushes; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; medical devices, namely, tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions; medical devices, namely, tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human whole blood for the purpose of separating human blood components for use in blood transfusions and washing human red blood cells with clinical medical reagents for use in blood transfusions; apparatus for the regeneration of stem cells for medical purposes | ACTIVE | — |
| 042 | Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; scientific research and development; research and development services in the field of cytology; stem cell research services; scientific research for medical purposes in the field of cancerous diseases; development of pharmaceutical preparations and medicines; medical research; design and development of medical technology, namely, product design and development in the field of cytology; scientific and medical research services in the field of proteins, antibodies, microorganisms and cells; scientific services, namely, scientific and medical research relating to the isolation and cultivation of human tissues and cells; scientific research, testing and analysis services, namely, scientific and medical laboratory services; industrial research, testing and analysis services, namely, scientific and medical industrial research, testing and analysis services in the field of cytology, stem cell research, cancerous diseases, pharmaceutical preparations and medicines, proteins, antibodies, microorganisms and cells, and isolation and cultivation of human tissues and cells; product quality testing services; design and development of diagnostic apparatus for others; tool design; industrial design; design of integrated circuits; design of engineering products; design of optical components; design of mechanical and micromechanical components; design of optical and microoptical components; design for others in the field of machinery; machine part design services; new product design services; diagnostic apparatus, circuit, engineering, optical and machinery design services; creating and maintaining websites for others; computer programming services; maintenance of computer programs; image processing software design; design and development of computer software; computer programming and software design; computer software design for others; design and writing of computer software; updating, design and rental of computer software for image processing; technological advice, namely, technology consultancy relating to computers, automobiles and industrial machines; testing and research services in the field of electricity; testing and research services relating to machines, apparatus and instruments, namely, testing the functionality of machines and research on machines; rental of measuring apparatus; rental of computer software and programs for image processing; providing online non-downloadable computer programs for image processing on data networks; cloud computing featuring software for use in image data management and analysis; cloud storage services for electronic data; cloud storage services for electronic files; providing temporary use of on-line non-downloadable cloud computing software for use in cellular and tissue image data storage and analysis; providing temporary use of non-downloadable cloud-based software for connecting, operating, and managing networked laboratory equipment in the internet of things (IoT); providing temporary use of non-downloadable web-based decentralized applications (DApps) for microscopic data browsing; providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for microscopic image analysis; updating and maintaining cloud-based computer software through on-line updates; leasing of laboratory computer apparatus | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 13, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 23, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 3, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 2, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 24, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 24, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 24, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 8, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 8, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 19, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 26, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 26, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 6, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 6, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 6, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 19, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 4, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 4, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 4, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 3, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 29, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 29, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 23, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |